Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)
Active, not recruiting · NCT06843239 · Registry updated 2026-07-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, diffuse scleroderma, immune system disorder, interstitial lung disease, lung disorder, respiratory system disorder, scleroderma, skin disorder, systemic sclerosis | Active, not recruiting | Phase 2 | 2026-07-20 | NCT06843239 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zura Bio Inc | 2 |
60 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.